Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Leukemia |
Vol/bind | 36 |
Sider (fra-til) | 2912-2916 |
ISSN | 0887-6924 |
DOI | |
Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:
The research was supported by Rigshospitalets Research Foundation and the Novo Nordisk Foundation (Novo Nordisk Foundation Center for Stem Cell Biology, DanStem; grant NNF17CC0027852). The project is part of the Danish Research Center for Precision Medicine in Blood Cancers funded by the Danish Cancer Society grant no. R223-A13071 and Greater Copenhagen Health Science Partners. The clinical trial was investigator-initiated and supported by Janssen and Celgene.
ID: 324127916